Jump to:
James Gould joined Ropes & Gray's corporate department in the Boston office in 2023. James graduated from Boston University School of Law in 2023 after attending College of the Holy Cross as an undergraduate.
During law school, James served as an editor on Boston University’s Journal of Science and Technology Law. As an undergraduate James studied chemistry and was named a Goldwater Scholar in 2019 for his research on self-assembled monolayers.
Experience
- Represented Amylyx Pharmaceuticals, a global pharmaceutical company focused on developing treatments for neurodegenerative diseases, in its successful bid of more than $35.1 million to purchase the avexitide assets of Eiger BioPharmaceuticals, Inc. in the sale of Eiger’s assets pursuant to Section 363 of the bankruptcy code.
- Represented Regeneron in acquisition of 2seventy Bio platforms to create new R&D unit Regeneron Cell Medicines.